SVP F&A, CFO, Treas & Asst Sec of Regeneron Pharmaceuticals Inc. (REGN, Financial) Murray A Goldberg sells 4,569 shares of REGN on 02/18/2011 at an average price of $37.18 a share.
Regeneron Pharmaceuticals Inc. has a market cap of $3.1 billion; its shares were traded at around $37.67 with and P/S ratio of 8.2.
Hedge Fund Gurus that owns REGN: Seth Klarman of The Baupost Group, Carl Icahn of Icahn Capital Management LP, Bruce Kovner of Caxton Associates, Jim Simons of Renaissance Technologies LLC, Steven Cohen of SAC Capital Advisors. Mutual Fund and Other Gurus that owns REGN: Edward Owens of Vanguard Health Care Fund, Chuck Royce of Royce& Associates.
For the complete insider trading history of REGN, click here.
Regeneron Pharmaceuticals Inc. has a market cap of $3.1 billion; its shares were traded at around $37.67 with and P/S ratio of 8.2.
Hedge Fund Gurus that owns REGN: Seth Klarman of The Baupost Group, Carl Icahn of Icahn Capital Management LP, Bruce Kovner of Caxton Associates, Jim Simons of Renaissance Technologies LLC, Steven Cohen of SAC Capital Advisors. Mutual Fund and Other Gurus that owns REGN: Edward Owens of Vanguard Health Care Fund, Chuck Royce of Royce& Associates.
CFO Recent Trades:
- Sell: SVP F&A, CFO, Treas & Asst Sec Murray A Goldberg sold 5,885 shares of REGN stock on 02/14/2011 at the average price of 37.32. Murray A Goldberg owns at least 82,870 shares after this. The price of the stock has increased by 0.94% since.
- Sell: SVP F&A, CFO, Treas & Asst Sec Murray A Goldberg sold 7,373 shares of REGN stock on 01/07/2011 at the average price of 34.09. Murray A Goldberg owns at least 82,870 shares after this. The price of the stock has increased by 10.5% since.
- Sell: SVP F&A, CFO, Treas & Asst Sec Murray A Goldberg sold 5,168 shares of REGN stock on 12/17/2010 at the average price of 32.15. Murray A Goldberg owns at least 48,870 shares after this. The price of the stock has increased by 17.17% since.
- Sell: SVP F&A, CFO, Treas & Asst Sec Murray A Goldberg sold 5,168 shares of REGN stock on 12/17/2010 at the average price of 32.15. Murray A Goldberg owns at least 48,870 shares after this. The price of the stock has increased by 17.17% since.
Directors and Officers Recent Trades:
- Buy: 10% Owner Sanofi-aventis bought 1,017,401 shares of REGN stock on 10/13/2010 at the average price of 28. Sanofi-aventis owns at least 15,816,953 shares after this. The price of the stock has increased by 34.54% since.
- Sell: SVP Commercial Robert J Terifay sold 5,000 shares of REGN stock on 02/14/2011 at the average price of 37.02. Robert J Terifay owns at least 1,106 shares after this. The price of the stock has increased by 1.76% since.
- Sell: Director Joseph L Goldstein sold 2,761 shares of REGN stock on 02/11/2011 at the average price of 36.66. The price of the stock has increased by 2.76% since.
- Sell: Director Joseph L Goldstein sold 5,401 shares of REGN stock on 01/27/2011 at the average price of 34.67. The price of the stock has increased by 8.65% since.
- Sell: VP Regul Devel & Med Safety William Roberts sold 2,693 shares of REGN stock on 01/26/2011 at the average price of 34.49. William Roberts owns at least 88,209 shares after this. The price of the stock has increased by 9.22% since.
For the complete insider trading history of REGN, click here.
